Richard Roden

25PUBLICATIONS
73CO-AUTHORS
Preventative health careCancer diagnosisInnate immunityPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 31, 2026
Developments in human papillomavirus vaccines, schedules, and implementation strategies.

|Aug 25, 2026
Application of Cobas 6800 HPV testing and qPCR utilizing three genomically-optimized primer sets for detecting HPV DNA in the blood of HPV Positive dysplasia and cancer patients.

|Aug 21, 2026
Factors impacting protective immunity conferred by vaccination with adeno-associated virus-like particles displaying human papillomavirus L2 residues 17-36.

|Jul 27, 2026
Exploration of immune correlates of viral clearance after PVX2 immunotherapy in patients with human papillomavirus type 16 infection and cervical intraepithelial neoplasia grade ≤1.

|Jan 15, 2025
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis.

Margaret Wong, Hsin-Fang Tu, Ssu-Hsieh Tseng

|Jul 11, 2024
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.

Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai

Pageof 5

Frequent Collaborators

2 joint publications

Samarjit Das

2 joint publications

T-C Wu

2 joint publications

Chien-Fu Hung

2 joint publications

Frank Stubenrauch